Latest Advances

  • Condition: Cutaneous Leishmaniasis
  • Journal: Acta dermato-venereologica
  • Treatment Used: Miltefosine
  • Number of Patients: 10
  • Published —
In this study, researchers evaluated the safety and effectiveness of miltefosine for the treatment of cutaneous leishmaniasis in children.
  • Condition: Lichen Planopilaris
  • Journal: International immunopharmacology
  • Treatment Used: Cyclosporine or Methotrexate
  • Number of Patients: 33
  • Published —
This study compared the clinical outcome of using cyclosporine or methotrexate to treat patients with lichen planopilaris.
  • Condition: Refractory Mucocutaneous Leishmaniasis (MCL)
  • Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
  • Treatment Used: Combined Intravenous Pentamidine, Oral Azole, Aerosolized Liposomal Amphotericin B, and Intralesional Meglumine Antimoniate
  • Number of Patients: 1
  • Published —
This case report describes a 65-year-old Italian male diagnosed with severe relapsing mucocutaneous leishmaniasis (parasite disease; MCL) treated with combined intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate.
  • Condition: Acne Vulgaris
  • Journal: Dermatologic therapy
  • Treatment Used: Probiotics
  • Number of Patients: 0
  • Published —
This article discusses the potential use of probiotics for the treatment of acne vulgaris.
  • Condition: Cutaneous and Mucocutaneous Leishmaniasis
  • Journal: The American journal of tropical medicine and hygiene
  • Treatment Used: Amphotericin B Deoxycholate, Amphotericin B Colloidal Dispersion, or Liposomal Amphotericin B
  • Number of Patients: 0
  • Published —
In this study, researchers sought to determine the most effective form of amphotericin B (AB) for the treatment of cutaneous and mucocutaneous leishmaniasis.
  • Condition: Refractory Lupoid Cutaneous Leishmaniasis (LCL) in Patients with Anthroponotic Cutaneous Leishmaniasis (ACL)
  • Journal: BMC infectious diseases
  • Treatment Used: Salvage Therapy with 0.09% Sodium Chlorosum in Amphiphilic Basic Cream
  • Number of Patients: 20
  • Published —
This study evaluated the safety and effectiveness of salvage therapy with 0.09% sodium chlorosum in amphiphilic basic cream for the treatment of refractory lupoid cutaneous leishmaniasis (LCL) in patients with anthroponotic cutaneous leishmaniasis (ACL) resistant to conventional treatments.
  • Condition: Cutaneous Leishmaniasis (CL) Associated with Systemic Lupus Erythematosus (SLE)
  • Journal: Le infezioni in medicina
  • Treatment Used: Sodium Antimony Gluconate (1.5 mg/5ml) for Three Weeks
  • Number of Patients: 1
  • Published —
This case report discusses a 22-year-old man treated with corticosteroid drugs to control the manifestations of systemic lupus erythematosus (SLE) who developed cutaneous leishmaniasis (CL).
  • Condition: Cutaneous leishmaniasis
  • Journal: International journal of pharmaceutical compounding
  • Treatment Used: Topical treatment
  • Number of Patients: 0
  • Published —
The study researched the effects of medication that can be rubbed on the skin in cutaneous leishmaniasis.
  • Condition: Malaria, leishmaniasis, Chagas disease, and dengue
  • Journal: Phytotherapy research : PTR
  • Treatment Used: Flavonoids
  • Number of Patients: 0
  • Published —
The study researched flavonoids (compound found in plants) to be used for creating medicines for malaria, leishmaniasis, Chagas disease, and dengue.
  • Condition: Cutaneous Leishmaniasis in Israel
  • Journal: International journal of pharmaceutical compounding
  • Treatment Used: 5% Paromomycin +12% Methylbenzethonium Chloride Ointment
  • Number of Patients: 0
  • Published —
This study discusses the treatment of cutaneous leishmaniasis (parasite disease) in Israel with paromomycin sulfate liposomal gel (free of the sensitizing methylbenzethonium chloride).
  • Condition: Atrophic Cutaneous Leishmaniasis Scars
  • Journal: Lasers in surgery and medicine
  • Treatment Used: Nonablative fractional 1,540?nm laser
  • Number of Patients: 30
  • Published —
The study researched the use of nonablative fractional 1,540?nm laser in patients with atrophic cutaneous leishmaniasis scars.
  • Condition: Mucosal Leishmaniasis (ML)
  • Journal: PloS one
  • Treatment Used: Liposomal Amphotericin B (L-AMB) vs. Other Therapies
  • Number of Patients: 71
  • Published —
This study evaluated the outcome of patients with mucosal leishmaniasis (skin parasite infection; ML) who were treated with liposomal amphotericin B (L-AMB).
Showing 1-12 of 26